» Articles » PMID: 35621029

Management of Type 1 Diabetes in Low- and Middle-income Countries: Comparative Health System Assessments in Kyrgyzstan, Mali, Peru and Tanzania

Abstract

Aims: To describe and compare the health system responses for type 1 diabetes in Kyrgyzstan, Mali, Peru and Tanzania.

Methods: The Rapid Assessment Protocol for Insulin Access, a multi-level assessment of the health system, was implemented in Kyrgyzstan, Mali, Peru and Tanzania using document reviews, site visits and interviews to assess the delivery of care and access to insulin.

Results: Despite the existence of noncommunicable or diabetes strategies and Universal Health Coverage policies including diabetes-related supplies, this has not necessarily translated into access to insulin or diabetes care for all. Insulin and related supplies were often unavailable and unaffordable. Across the four countries test strips and insulin, when paid for by the individual, represented respectively 48-82% and 25-36% of total costs. Care was mainly delivered at tertiary-level hospitals by specialists. Only Kyrgyzstan had data collection systems integrated into the Ministry of Health structure. In addition, issues with healthcare worker training and education and empowerment of people with diabetes were present in these health systems.

Conclusions: People with type 1 diabetes in these countries face different barriers, including the cost of insulin and care. Given the renewed attention to diabetes on the global health agenda tailored health system responses for type 1 diabetes are needed. Insulin should be prioritized as it is the foundation of type 1 diabetes care, but other elements of care and support need to be fostered by different actors.

Citing Articles

Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries.

Ewen M, Lepeska M, Abdraimova A, Besancon S, Cham N, Dunganova A BMJ Public Health. 2025; 3(1):e001128.

PMID: 40017936 PMC: 11865750. DOI: 10.1136/bmjph-2024-001128.


Human versus Analogue Insulin for Youth with Type 1 Diabetes in Low-Resource Settings (HumAn-1): protocol for a randomised controlled trial.

Foulds A, Josey C, Kehlenbrink S, Rollman B, Chang C, Lalama C BMJ Open. 2025; 15(1):e092432.

PMID: 39890140 PMC: 11795411. DOI: 10.1136/bmjopen-2024-092432.


Availability, price and affordability of insulin, delivery devices and self-monitoring blood glucose devices in Indonesia.

Ramadaniati H, Anggriani Y, Lepeska M, Beran D, Ewen M PLoS One. 2024; 19(10):e0309350.

PMID: 39361609 PMC: 11449349. DOI: 10.1371/journal.pone.0309350.


Determinants of Self-monitoring of Blood Glucose in Iranian Children and Adolescents with Type 1 Diabetes.

Fayyaz F, Khosravi S, Mosallanejad A, Tabatabaei-Malazy O, Hashemi Nazari S, Shaghaghi M Int J Endocrinol Metab. 2024; 21(4):e138377.

PMID: 38666044 PMC: 11041815. DOI: 10.5812/ijem-138377.


User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.

Safary E, Beran D, Vetter B, Lepeska M, Abdraimova A, Dunganova A BMJ Open. 2024; 14(2):e076685.

PMID: 38367964 PMC: 10875487. DOI: 10.1136/bmjopen-2023-076685.


References
1.
Abdraimova A, Besancon S, Portocarrero J, Ramaiya K, Dunganova A, Ewen M . Management of type 1 diabetes in low- and middle-income countries: Comparative health system assessments in Kyrgyzstan, Mali, Peru and Tanzania. Diabet Med. 2022; 39(8):e14891. PMC: 9543552. DOI: 10.1111/dme.14891. View

2.
Livingstone S, Levin D, Looker H, Lindsay R, Wild S, Joss N . Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015; 313(1):37-44. PMC: 4426486. DOI: 10.1001/jama.2014.16425. View

3.
Sandy J, Besancon S, Sidibe A, Minkailou M, Togo A, Ogle G . Rapid increases in observed incidence and prevalence of Type 1 diabetes in children and youth in Mali, 2007-2016. Pediatr Diabetes. 2021; 22(4):545-551. DOI: 10.1111/pedi.13191. View

4.
Green A, Hede S, Patterson C, Wild S, Imperatore G, Roglic G . Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021; 64(12):2741-2750. PMC: 8563635. DOI: 10.1007/s00125-021-05571-8. View

5.
Beran D, Perel P, Miranda J . Forty years since Alma-Ata: do we need a new model for noncommunicable diseases?. J Glob Health. 2019; 9(1):010316. PMC: 6551545. DOI: 10.7189/jogh.09.010316. View